Filing Flows › Biofrontera (BFRI) › Q2 2026
Biofrontera (BFRI) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 13, 2026
Biofrontera (BFRI) reported revenue of $12.0M for the second quarter 2026 (Q2 2026), +33% from a year earlier and +19% from the quarter before. Operating margin was -4.4%, net loss $604K (5.0% of revenue).
Biofrontera, Q2 2026: revenue $12.0M (+33% year over year), operating margin -4.4%, net loss $604K, operating cash flow −$1.7M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $12.0M | +19% | +33% |
| Operating profit | −$524K | — | — |
| Net earnings | −$604K | — | — |
| Operating cash flow | −$1.7M | — | — |
What changed
Revenue was $12.0M in Q2 2026, up 33% year over year and up 19% from the previous quarter.
Operating costs exceeded revenue by $524K, an operating margin of -4.4%. Total costs fell 11% while revenue rose 33%. The quarter ended with a net loss of $604K, narrower than the previous quarter's $4.8M loss.
Operating cash flow was −$1.7M. Non-cash charges added back $65K of depreciation and amortization and $263K of share-based compensation. Working capital and other items used $1.4M.
Questions
What was Biofrontera's revenue in the second quarter 2026?
Biofrontera (BFRI) reported revenue of $12.0M for the second quarter 2026 (Q2 2026), +33% from a year earlier and +19% from the quarter before.
Was Biofrontera profitable in the second quarter 2026?
Operating loss was $524K (-4.4% of revenue) and net loss $604K.
Source: Biofrontera 10-Q on SEC EDGAR.